MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients

    M. Murata, M. Nakamura, H. Maruyama (Tokyo, Japan)

  • Efficacy and feasibility study of the Medido eletronic medication dispenser in Parkinson’s disease: A multicentre randomized controlled trial

    K. Hannink, L. ter Brake, A. Wertenbroek, K. Movig, J. van der Palen, L. Dorresteijn (Enschede, Netherlands)

  • Efficacy and safety of a L-dopa delivery and monitoring medical device

    Y.G. Tirat-Gefen (Fairfax, VA, USA)

  • Efficacy and safety of abobotulinumtoxinA in craniocervical dystonia and hemifacial spasm

    A. Jesic, D. Stefanovic, N. Delibasic, J. Radanov, M. Cvijanovic (Victoria, Seychelles)

  • Efficacy and safety of tetrabenazine in hyperkinetic movements disorders- An observational study

    R. Miguel, M. Mendonça, R. Barbosa, F. Ladeira, T. Lampreia, J. Vale, P. Bugalho (Lisbon, Portugal)

  • Efficacy of 4845 botulinum toxin (BoNT) treatment cycles, and clinical strategies after a failed cycle

    P. Tanvijit, A.P. Moore (Bangkok, Thailand)

  • Efficacy of apomorphine subcutaneous injections in patients with levodopa dose failures and morning akinesia

    S.H. Isaacson (Boca Raton, FL, USA)

  • Efficacy of deep brain stimulation (DBS) patient education and post operative support: A summary of 3 months monitoring of unscheduled patient phone requests. An Australian private neurology clinic experience

    K.A. O'Maley, P. Poortvliet, L.J. Cooke, P.A. Silburn (Brisbane, Australia)

  • Efficacy of long-term treatment with istradefylline and analysis of the expression of A2A receptor protein and post-transcriptional DNA methylation

    N. Kanzato, K. Nakachi, T. Naka, M. Higa, S. Mochizuki, Y. Miyamae (Okinawa Prefecture, Haebaru-cho, Japan)

  • Efficacy of the bilateral subthalamic stimulation in Parkinson’s disease, results from the Neuromodulation Centre in Budapest

    A. Kelemen, L. Eröss, D. Albert, I. Rózsa, E. Csibri, L. Entz, D. Fabó, L. Halász, G. Rudas, P. Barsi, P. Golopencza, G. Tamás (Budapest, Hungary)

  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 207
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley